Showing results (1-10 of 610) with videos related to
Sort By:
Pageof 61
Therapeutic Advances in Psychopharmacology|April 3, 2018
The antipsychotic landscape: dopamine and beyondPaul D Morrison, Robin M MurrayDialogues in Clinical Neuroscience|November 9, 2020
Cannabis points to the synaptic pathology of mental disorders: how aberrant synaptic components disrupt the highest psychological functionsPaul D Morrison, Robin M MurrayCurrent Opinion in Psychiatry|April 7, 2007
Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?Marta Di Forti, Paul D Morrison, Alexander Butt, et al.Nature Reviews. Neuroscience|October 11, 2007
Cannabis, the mind and society: the hash realitiesRobin M Murray, Paul D Morrison, Cécile Henquet, et al.Frontiers in Behavioral Neuroscience|January 27, 2011
Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of lightAlessandra Paparelli, Marta Di Forti, Paul D Morrison, et al.Journal of Psychopharmacology (Oxford, England)|March 31, 2026
The unique efficacy of clozapine is attributable to muscarinic receptor agonismPaul D Morrison, Robin M Murray, Sameer Jauhar, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 18, 2013
What can we learn about schizophrenia from studying the human model, drug-induced psychosis?Robin M Murray, Alessandra Paparelli, Paul D Morrison, et al.Neurotoxicity Research|December 17, 2008
What is the mechanism whereby cannabis use increases risk of psychosis?Sonija Luzi, Paul D Morrison, John Powell, et al.Schizophrenia Research|June 29, 2013
Persecutory ideation and a history of cannabis useDaniel Freeman, Paul D Morrison, Robin M Murray, et al.Schizophrenia Research|June 29, 2010
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplinesRebecca Kuepper, Paul D Morrison, Jim van Os, et al.Pageof 61